| HGNC Family | Solute carriers (SLC) |
| Name | solute carrier family 5 (sodium/glucose cotransporter), member 1 |
| Description | This gene encodes a member of the sodium-dependent glucose transporter (SGLT) family. The encoded integral membrane protein is the primary mediator of dietary glucose and galactose uptake from the intestinal lumen. Mutations in this gene have been associated with glucose-galactose malabsorption. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSLC5A1, which encodes the sodium‐glucose cotransporter 1 (SGLT1), plays a critical role in active glucose uptake across multiple epithelia. In the kidney, although the bulk of filtered glucose reabsorption is mediated by its close homolog SGLT2, SGLT1 is responsible for reabsorbing residual glucose in the later segments of the proximal tubule, thereby contributing to overall glucose homeostasis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In the intestine, SGLT1‐mediated glucose uptake is essential not only for nutrient absorption but also for cytoprotection against enterocyte apoptosis and barrier dysfunction induced by bacterial products, and its activity is modulated by external glucose concentrations and specific inhibitors such as phloridzin."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Furthermore, beyond its classical roles in the gut and kidney, SGLT1 is expressed in the heart where it contributes to cardiomyocyte glucose uptake"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": ", and its critical importance is underscored by mutations in SLC5A1 that cause glucose–galactose malabsorption, a life‐threatening neonatal disorder."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " In addition, altered SGLT1 expression has been implicated in various pathological contexts including enhanced glucose absorption in diabetes"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": ", modulation by dietary polyphenols in the gut"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": ", and aberrant expression in several cancers that in some cases correlates with prognosis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "10", "end_ref": "13"}]}, {"type": "t", "text": " Moreover, recent findings have extended the physiological relevance of SGLT1 to reproductive tissues where its expression influences endometrial glycogen storage and pregnancy outcomes."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAt the molecular level, extensive biophysical and structural studies have delineated key aspects of SGLT1 function. Investigations utilizing polarized intestinal cell models revealed that a substantial intracellular reserve of SGLT1 exists, which may be mobilized for regulated expression at the apical membrane."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": " Cryo‐electron microscopy and molecular dynamics simulations have provided insights into the architecture of SGLT1, uncovering the substrate binding and selectivity mechanisms that govern cotransport activity."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "16"}]}, {"type": "t", "text": " Functional reconstitution experiments and voltage‐jump analyses in heterologous expression systems further defined the kinetics of conformational transitions during the transport cycle"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "18"}]}, {"type": "t", "text": ", while analyses of intrinsic tryptophan fluorescence and cysteine‐targeted labeling have revealed critical disulfide interactions that influence transporter conformation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "20"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nSGLT1 function is subject to multifaceted regulation by cellular signaling pathways and interacting proteins. Activation of energy‐sensing kinases, such as AMPK, has been shown to promote the translocation of SGLT1 to the plasma membrane, thereby enhancing its activity."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "21"}]}, {"type": "t", "text": " In parallel, the circadian clock component PER1 regulates SGLT1 transcription in renal proximal tubules, linking transporter expression to daily variations in sodium and glucose homeostasis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "22"}]}, {"type": "t", "text": " Pharmacological inhibitors, including novel thioglycoside derivatives, competitively inhibit SGLT1 with distinct selectivity, providing a therapeutic avenue to modulate glucose absorption."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "23"}]}, {"type": "t", "text": " Endothelial studies have further implicated SGLT1 in mediating the uptake of bioactive compounds such as anthocyanins, which in turn influence cellular oxidative stress and mitochondrial function"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "24"}]}, {"type": "t", "text": ", while overexpression of regulatory proteins like MAP17 and viral oncoproteins (e.g. HPV E6) enhance SGLT1 expression in tumor cells, linking its activity to cancer cell survival."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "25", "end_ref": "28"}]}, {"type": "t", "text": " Genetic studies have also identified variants in SLC5A1 that modulate its function and are associated with altered glucose handling and diabetic excursions, underscoring its clinical significance."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "29"}]}, {"type": "t", "text": " Finally, additional evidence from tumor cell models indicates that SGLT1 upregulation supports intracellular glucose levels and may complement kinase‐independent activities of receptors such as IGF‐1R in sustaining cell viability."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "30"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Charles S Hummel, Chuan Lu, Donald D F Loo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Glucose transport by human renal Na+/D-glucose cotransporters SGLT1 and SGLT2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Cell Physiol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpcell.00388.2010"}], "href": "https://doi.org/10.1152/ajpcell.00388.2010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20980548"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20980548"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Chiara Ghezzi, Donald D F Loo, Ernest M Wright "}, {"type": "b", "children": [{"type": "t", "text": "Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetologia (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00125-018-4656-5"}], "href": "https://doi.org/10.1007/s00125-018-4656-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30132032"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30132032"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Susana Manzano, Gary Williamson "}, {"type": "b", "children": [{"type": "t", "text": "Polyphenols and phenolic acids from strawberry and apple decrease glucose uptake and transport by human intestinal Caco-2 cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Nutr Food Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mnfr.201000019"}], "href": "https://doi.org/10.1002/mnfr.201000019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20564476"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20564476"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Linda C H Yu, Andrew N Flynn, Jerrold R Turner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SGLT-1-mediated glucose uptake protects intestinal epithelial cells against LPS-induced apoptosis and barrier defects: a novel cellular rescue mechanism?"}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.05-4226com"}], "href": "https://doi.org/10.1096/fj.05-4226com"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16260652"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16260652"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Sanjay K Banerjee, Kenneth R McGaffin, Núria M Pastor-Soler, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cardiovasc Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/cvr/cvp190"}], "href": "https://doi.org/10.1093/cvr/cvp190"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19509029"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19509029"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Yusuke Kashiwagi, Tomohisa Nagoshi, Takuya Yoshino, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of SGLT1 in Human Hearts and Impairment of Cardiac Glucose Uptake by Phlorizin during Ischemia-Reperfusion Injury in Mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0130605"}], "href": "https://doi.org/10.1371/journal.pone.0130605"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26121582"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26121582"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Ernest M Wright, Eric Turk, Martin G Martin "}, {"type": "b", "children": [{"type": "t", "text": "Molecular basis for glucose-galactose malabsorption."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Biochem Biophys (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1385/CBB:36:2-3:115"}], "href": "https://doi.org/10.1385/CBB:36:2-3:115"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12139397"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12139397"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Rebekah Lambert, Sarah Srodulski, Xiaoli Peng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Intracellular Na+ Concentration ([Na+]i) Is Elevated in Diabetic Hearts Due to Enhanced Na+-Glucose Cotransport."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Am Heart Assoc (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/JAHA.115.002183"}], "href": "https://doi.org/10.1161/JAHA.115.002183"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26316524"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26316524"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Fawaz Alzaid, Hoi-Man Cheung, Victor R Preedy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of glucose transporter expression in human intestinal Caco-2 cells following exposure to an anthocyanin-rich berry extract."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0078932"}], "href": "https://doi.org/10.1371/journal.pone.0078932"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24236070"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24236070"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Veerle F Casneuf, Philippe Fonteyne, Nancy Van Damme, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Invest (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/07357900801956363"}], "href": "https://doi.org/10.1080/07357900801956363"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18853313"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18853313"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Luke Norton, Christopher E Shannon, Marcel Fourcaudot, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sodium-glucose co-transporter (SGLT) and glucose transporter (GLUT) expression in the kidney of type 2 diabetic subjects."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes Obes Metab (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/dom.13003"}], "href": "https://doi.org/10.1111/dom.13003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28477418"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28477418"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Anna Solini, Chiara Rossi, Chiara M Mazzanti, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sodium-glucose co-transporter (SGLT)2 and SGLT1 renal expression in patients with type 2 diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes Obes Metab (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/dom.12970"}], "href": "https://doi.org/10.1111/dom.12970"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28419670"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28419670"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Gui Fang Guo, Yu Chen Cai, Bei Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of SGLT1 and EGFR in colorectal cancer showing a correlation with the prognosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Oncol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12032-010-9696-8"}], "href": "https://doi.org/10.1007/s12032-010-9696-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21080109"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21080109"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Madhuri S Salker, Yogesh Singh, Ni Zeng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of Endometrial Sodium Glucose Cotransporter SGLT1 is Detrimental to Embryo Survival and Fetal Growth in Pregnancy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-017-11674-3"}], "href": "https://doi.org/10.1038/s41598-017-11674-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28974690"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28974690"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Helmut Kipp, Saeed Khoursandi, Daniel Scharlau, et al. "}, {"type": "b", "children": [{"type": "t", "text": "More than apical: Distribution of SGLT1 in Caco-2 cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Cell Physiol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpcell.00041.2003"}], "href": "https://doi.org/10.1152/ajpcell.00041.2003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12773314"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12773314"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Lei Han, Qianhui Qu, Deniz Aydin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structure and mechanism of the SGLT family of glucose transporters."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41586-021-04211-w"}], "href": "https://doi.org/10.1038/s41586-021-04211-w"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34880492"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34880492"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Thomas Zeuthen, Bo Belhage, Emil Zeuthen "}, {"type": "b", "children": [{"type": "t", "text": "Water transport by Na+-coupled cotransporters of glucose (SGLT1) and of iodide (NIS). The dependence of substrate size studied at high resolution."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Physiol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1113/jphysiol.2005.100933"}], "href": "https://doi.org/10.1113/jphysiol.2005.100933"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16322051"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16322051"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Sara B Seidelmann, Elena Feofanova, Bing Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic Risk."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Am Coll Cardiol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jacc.2018.07.061"}], "href": "https://doi.org/10.1016/j.jacc.2018.07.061"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30286918"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30286918"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Donald D F Loo, Bruce A Hirayama, Movses H Karakossian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Conformational dynamics of hSGLT1 during Na+/glucose cotransport."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Gen Physiol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1085/jgp.200609643"}], "href": "https://doi.org/10.1085/jgp.200609643"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17130520"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17130520"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Dominique G Gagnon, Pierre Bissonnette, Jean-Yves Lapointe "}, {"type": "b", "children": [{"type": "t", "text": "Identification of a disulfide bridge linking the fourth and the seventh extracellular loops of the Na+/glucose cotransporter."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Gen Physiol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1085/jgp.200509439"}], "href": "https://doi.org/10.1085/jgp.200509439"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16446504"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16446504"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Mentor Sopjani, Shefalee K Bhavsar, Scott Fraser, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of Na+-coupled glucose carrier SGLT1 by AMP-activated protein kinase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Membr Biol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3109/09687681003616870"}], "href": "https://doi.org/10.3109/09687681003616870"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20334581"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20334581"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Kristen Solocinski, Jacob Richards, Sean All, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcriptional regulation of NHE3 and SGLT1 by the circadian clock protein Per1 in proximal tubule cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Renal Physiol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajprenal.00197.2014"}], "href": "https://doi.org/10.1152/ajprenal.00197.2014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26377793"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26377793"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Francisco Castaneda, Antje Burse, Wilhelm Boland, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Thioglycosides as inhibitors of hSGLT1 and hSGLT2: potential therapeutic agents for the control of hyperglycemia in diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Med Sci (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/ijms.4.131"}], "href": "https://doi.org/10.7150/ijms.4.131"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17505558"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17505558"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Xin Jin, Long Yi, Ming-liang Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Delphinidin-3-glucoside protects against oxidized low-density lipoprotein-induced mitochondrial dysfunction in vascular endothelial cells via the sodium-dependent glucose transporter SGLT1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0068617"}], "href": "https://doi.org/10.1371/journal.pone.0068617"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23874689"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23874689"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Marco Perez, Juan M Praena-Fernandez, Blanca Felipe-Abrio, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MAP17 and SGLT1 protein expression levels as prognostic markers for cervical tumor patient survival."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0056169"}], "href": "https://doi.org/10.1371/journal.pone.0056169"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23418532"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23418532"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "B Xin, H Wang "}, {"type": "b", "children": [{"type": "t", "text": "Multiple sequence variations in SLC5A1 gene are associated with glucose-galactose malabsorption in a large cohort of Old Order Amish."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Genet (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1399-0004.2010.01440.x"}], "href": "https://doi.org/10.1111/j.1399-0004.2010.01440.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20486940"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20486940"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Alexandra Vernaleken, Maike Veyhl, Valentin Gorboulev, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tripeptides of RS1 (RSC1A1) inhibit a monosaccharide-dependent exocytotic pathway of Na+-D-glucose cotransporter SGLT1 with high affinity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M705416200"}], "href": "https://doi.org/10.1074/jbc.M705416200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17686765"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17686765"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Huiquan Liu, Ayse Ertay, Ping Peng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SGLT1 is required for the survival of triple-negative breast cancer cells via potentiation of EGFR activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Oncol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/1878-0261.12530"}], "href": "https://doi.org/10.1002/1878-0261.12530"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31199048"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31199048"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Man Li, Nisa M Maruthur, Stephanie J Loomis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genome-wide association study of 1,5-anhydroglucitol identifies novel genetic loci linked to glucose metabolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-017-02287-x"}], "href": "https://doi.org/10.1038/s41598-017-02287-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28588231"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28588231"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Natalie Leiprecht, Carlos Munoz, Ioana Alesutan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of Na(+)-coupled glucose carrier SGLT1 by human papillomavirus 18 E6 protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2010.12.044"}], "href": "https://doi.org/10.1016/j.bbrc.2010.12.044"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21156162"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21156162"}]}]}]}
|
| Synonyms | SGLT1, D22S675, NAGT |
| Proteins | SC5A1_HUMAN |
| NCBI Gene ID | 6523 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
SLC5A1 has 5,308 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, disease, phenotype or trait, functional term, phrase or reference, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 112 datasets.
Click the + buttons to view associations for SLC5A1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of SLC5A1 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SLC5A1 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of SLC5A1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of SLC5A1 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC5A1 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SLC5A1 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of SLC5A1 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of SLC5A1 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of SLC5A1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC5A1 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with SLC5A1 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC5A1 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of SLC5A1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of SLC5A1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations | phenotypes associated with SLC5A1 gene from the curated ClinVar Gene-Phenotype Associations dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with SLC5A1 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SLC5A1 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing SLC5A1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing SLC5A1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with SLC5A1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with SLC5A1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with SLC5A1 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with SLC5A1 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with SLC5A1 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by SLC5A1 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with SLC5A1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with SLC5A1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with SLC5A1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with SLC5A1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for SLC5A1 protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SLC5A1 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC5A1 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of SLC5A1 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing SLC5A1 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with SLC5A1 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with SLC5A1 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC5A1 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with SLC5A1 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing SLC5A1 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of SLC5A1 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SLC5A1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of SLC5A1 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of SLC5A1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of SLC5A1 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of SLC5A1 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GlyGen Glycosylated Proteins | ligands (chemical) binding SLC5A1 protein from the GlyGen Glycosylated Proteins dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving SLC5A1 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving SLC5A1 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving SLC5A1 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing SLC5A1 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing SLC5A1 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing SLC5A1 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by SLC5A1 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by SLC5A1 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by SLC5A1 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of SLC5A1 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of SLC5A1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of SLC5A1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SLC5A1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| Guide to Pharmacology Chemical Ligands of Receptors | ligands (chemical) binding SLC5A1 receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with SLC5A1 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with SLC5A1 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with SLC5A1 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of SLC5A1 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for SLC5A1 protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of SLC5A1 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of SLC5A1 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of SLC5A1 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HPO Gene-Disease Associations | phenotypes associated with SLC5A1 gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for SLC5A1 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with SLC5A1 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for SLC5A1 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of SLC5A1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of SLC5A1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of SLC5A1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways 2026 | pathways involving SLC5A1 protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of SLC5A1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with SLC5A1 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of SLC5A1 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of SLC5A1 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of SLC5A1 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing SLC5A1 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain SLC5A1 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by SLC5A1 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting SLC5A1 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of SLC5A1 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of SLC5A1 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by SLC5A1 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of SLC5A1 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with SLC5A1 gene from the curated OMIM Gene-Disease Associations dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for SLC5A1 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of SLC5A1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of SLC5A1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving SLC5A1 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving SLC5A1 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2014 | pathways involving SLC5A1 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving SLC5A1 protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of SLC5A1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at SLC5A1 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of SLC5A1 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of SLC5A1 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of SLC5A1 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of SLC5A1 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of SLC5A1 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of SLC5A1 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of SLC5A1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SLC5A1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of SLC5A1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of SLC5A1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with SLC5A1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with SLC5A1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2024 | pathways involving SLC5A1 protein from the WikiPathways Pathways 2024 dataset. | |